)J)3_M$$HW;%TV]}1,QE}T01EOI43GF4,KT&
SYSTEM PROCESSING...
)J)3_M$$HW;%TV]}1,QE}T01EOI43GF4,KT&
SYSTEM PROCESSING...
Posted: 2025-05-16 06:46:38 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-05-16 06:47:03 UTC
Verified By
Rollup News
A baby with CPS1 deficiency, a rare and often fatal metabolic condition, was saved by a personalized gene therapy developed in under a year, showcasing the potential of rapid gene therapy development.
Successful N-of-1 gene therapy for CPS1 deficiency
Rapid development of personalized gene therapy
Potential for scaling gene therapy platforms
Regulatory changes needed to accelerate gene therapy
High mortality rate of early-onset CPS1 deficiency
Need for dialysis, restrictive dieting, or liver transplantation for survivors
Regulatory hurdles in developing and approving gene therapies
Identifying patients for personalized gene therapies